SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-14-074012
Filing Date
2014-10-27
Accepted
2014-10-27 16:38:50
Documents
5
Period of Report
2014-12-02
Effectiveness Date
2014-10-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A a14-14205_6def14a.htm DEF 14A 452272
2 GRAPHIC g142056bci001.jpg GRAPHIC 6023
3 GRAPHIC g142056bgi001.jpg GRAPHIC 4789
4 GRAPHIC g142056cai001.gif GRAPHIC 89860
5 GRAPHIC g142056cai002.gif GRAPHIC 18019
  Complete submission text file 0001104659-14-074012.txt   617465
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 000-55020 | Film No.: 141174896
SIC: 2834 Pharmaceutical Preparations